Related Experiment Video
Updated: Oct 24, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.6K
Pneumonia initiates a tauopathy.
Ron Balczon1,2, Mike T Lin2,3, Ji Young Lee2,3,4
1Department of Biochemistry and Molecular Biology, University of South Alabama, Mobile, AL, USA.
Summary
Pneumonia triggers toxic amyloid and tau proteins in the blood, leading to cognitive dysfunction by impairing brain function. This tauopathy contributes to memory loss and thinking problems after infection.
Area of Science:
- Neuroscience
- Pathology
- Infectious Diseases
Background:
- Pneumonia frequently causes cognitive dysfunction, but the underlying mechanisms remain unclear.
- Amyloid and tau proteins are implicated in neurodegenerative diseases and cognitive decline.
Purpose of the Study:
- To investigate if pneumonia generates cytotoxic amyloid and tau variants.
- To determine if these variants impair hippocampal function and long-term potentiation (LTP).
- To assess the role of tau in pneumonia-induced cognitive deficits.
Main Methods:
- Detected amyloid and tau species in blood and hippocampus post-pneumonia.
- Introduced blood-borne amyloid and tau into uninfected animals.
- Evaluated LTP in wild-type and tau knockout mice following pneumonia or amyloid/tau administration.
Main Results:
- Cytotoxic amyloid and tau were found in circulation and brain tissue after pneumonia, and in extracorporeal membrane oxygenation (ECMO) circuits of severe cases.
- Infusion of these variants impaired hippocampal processing and LTP in animals.
- Tau knockout mice showed resistance to infection-induced LTP impairment and amyloid/tau variant generation.
Conclusions:
- Pneumonia induces a tauopathy through circulating cytotoxic amyloid and tau variants.
- These variants contribute to cognitive dysfunction by disrupting hippocampal signaling.
- Targeting tau may offer therapeutic strategies for post-pneumonia cognitive deficits.
Related Concept Videos
Pneumonia II: Pathophysiology
1.1K
The pathophysiology of pneumonia involves the following steps:
1.1K
Pneumonia I: Introduction
425
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
425
Pulmonary Tuberculosis II
697
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
697
Pneumonia III: Complications and Assessment
533
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
533
Pneumonia IV: Management
519
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
519
Pneumonia V: Nursing management and Prevention
2.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K

